Timing of Tracheostomy in COVID-19 - Impact on Mortality

Completed

• Conditions: Tracheostomy

• Registration Number: NCT05175859
• Lead Sponsor: Goethe University

Brief Summary

How timing of tracheostomy in COVID-19 patients changed and its impact on mortality in patients with severe COVID-19 ARDS

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-01
• Primary Completion: 2021-10-01
• Status Verified: 2021-12
• Study Completion: 2021-12-25
• Study First Submitted: 2021-12-26
• Study First Submitted QC: 2021-12-28
• Last Update Submitted: 2021-12-28
• Study First Posted: 2022-01-04
• Last Update Posted: 2022-01-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 117

Inclusion Criteria

• Severe COVID-19 infection requiring endotracheal intubation and prolonged invasive ventilation as part of the treatment of severe to moderate acute respiratory distress syndrome.

Exclusion Criteria

• COVID-19 disease, without the need for endotracheal ventilation.
• COVID-19 disease with need for endotracheal intubation with anticipated short-term invasive ventilation.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality	During intensive care treatment (Usually within 8 weeks)	Deaths in the course of treatment

Trial Locations

Locations (1)

University Hospital Frankfurt; 🇩🇪 Frankfurt Niederrad, Hessen, Germany